Trinity Biotech (TRIB)
(Delayed Data from NSDQ)
$3.20 USD
-0.10 (-3.03%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $3.19 -0.01 (-0.31%) 7:18 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TRIB 3.20 -0.10(-3.03%)
Will TRIB be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for TRIB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TRIB
Trinity Biotech (TRIB) to Grow in Wearable Biosensor With Buyout
TRIB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for TRIB
Trinity Biotech Announces Appointment of A New CFO
Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM Sensor
Trinity Biotech to begin European pre-pivotal trial for CGM sensor
Trinity Biotech files for $50M mixed shelf offering
Trinity Biotech files $50M mixed securities shelf